---
title: "KRYS.US (KRYS.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/KRYS.US/news.md"
symbol: "KRYS.US"
name: "KRYS.US"
parent: "https://longbridge.com/en/quote/KRYS.US.md"
datetime: "2026-05-21T21:41:40.582Z"
locales:
  - [en](https://longbridge.com/en/quote/KRYS.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KRYS.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KRYS.US/news.md)
---

# KRYS.US (KRYS.US) — Related News

### [Krystal Biotech's Medicine to Treat Wounds in Dystrophic Epidermolysis Bullosa Gets Approval in UK](https://longbridge.com/en/news/286606318.md)
*2026-05-15T19:36:00.000Z*
> Krystal Biotech's beremagene geperpavec has received approval from the UK's Medicines and Healthcare products Regulatory

### [Krystal Biotech (NASDAQ:KRYS) Hits New 52-Week High  - Here's Why](https://longbridge.com/en/news/285967989.md)
*2026-05-11T15:37:26.000Z*
> Krystal Biotech (NASDAQ:KRYS) reached a new 52-week high of $314.00, closing at $310.63 with a trading volume of 23,480 

### [HC Wainwright Expects Increased Earnings for Krystal Biotech](https://longbridge.com/en/news/285376490.md)
*2026-05-06T12:21:31.000Z*
> HC Wainwright has raised its FY2026 earnings estimate for Krystal Biotech (NASDAQ:KRYS) from $5.78 to $6.83 per share, m

### [Krystal Biotech Analysts Boost Their Forecasts Following Upbeat Q1 Results](https://longbridge.com/en/news/285249366.md)
*2026-05-05T18:19:56.000Z*
> Krystal Biotech (KRYS) reported strong Q1 earnings, with earnings of $1.83 per share and sales of $116.357 million, both

### [Krystal Biotech Earnings Call Highlights Profitable Growth](https://longbridge.com/en/news/285140106.md)
*2026-05-05T00:24:41.000Z*
> Krystal Biotech's Q1 earnings call highlighted strong revenue growth, with net revenue for VYJUVEK reaching $116.4 milli

### [Juheng News - Factset's latest survey: Krystal Biotech Inc (KRYS-US) EPS estimate revised up to 7.99 yuan, estimated target price is 311.00 yuan](https://longbridge.com/en/news/285129897.md)
*2026-05-04T22:15:45.000Z*
> According to the latest survey by FactSet, the median EPS estimate for Krystal Biotech Inc (KRYS-US) for 2026 has been r

### [Guancha News - Factset's latest survey: Krystal Biotech Inc KRYS-US's target price has been lowered to 311 yuan, a decrease of approximately 3.72%](https://longbridge.com/en/news/285115890.md)
*2026-05-04T20:15:33.000Z*
> According to the latest survey by FactSet, the median target price for Krystal Biotech Inc (KRYS-US) has been lowered fr

### [Chardan Capital Keeps Their Buy Rating on Krystal Biotech (KRYS)](https://longbridge.com/en/news/285111709.md)
*2026-05-04T19:45:37.000Z*
> Chardan Capital has maintained a Buy rating on Krystal Biotech (KRYS) with a price target of $323. Analyst Geulah Livshi

### [Krystal Biotech's first-quarter performance exceeded expectations, with global revenue of $116 million for the gene therapy VYJUVEK](https://longbridge.com/en/news/285110563.md)
*2026-05-04T19:28:51.000Z*
> Gene therapy company Krystal Biotech released its Q1 2026 financial report, with global sales of its core product VYJUVE